Manulife (Manufacturers Life Insurance)
DAWN

Manulife (Manufacturers Life Insurance)’s Day One Biopharmaceuticals DAWN Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$776K Buy
36,186
+11,943
+49% +$168K ﹤0.01% 1959
2025
Q4 		$226K Sell
24,243
-1,224
-5% -$10.2K ﹤0.01% 2474
2025
Q3 		$180K Sell
25,467
-12,737
-33% -$87.6K ﹤0.01% 2618
2025
Q2 		$248K Buy
38,204
+8,496
+29% +$58.4K ﹤0.01% 2461
2025
Q1 		$236K Sell
29,708
-17,291
-37% -$186K ﹤0.01% 2424
2024
Q4 		$595K Sell
46,999
-1,489
-3% -$20.7K ﹤0.01% 2150
2024
Q3 		$675K Buy
48,488
+214
+0.4% +$3.05K ﹤0.01% 2121
2024
Q2 		$665K Sell
48,274
-2,094
-4% -$30.6K ﹤0.01% 2079
2024
Q1 		$832K Buy
50,368
+9,490
+23% +$142K ﹤0.01% 1951
2023
Q4 		$597K Sell
40,878
-538
-1% -$6.52K ﹤0.01% 2096
2023
Q3 		$508K Sell
41,416
-22,297
-35% -$291K ﹤0.01% 2133
2023
Q2 		$761K Buy
63,713
+8,464
+15% +$111K ﹤0.01% 1794
2023
Q1 		$739K Sell
55,249
-3,905
-7% -$76.3K ﹤0.01% 1771
2022
Q4 		$1.26M Buy
59,154
+1,697
+3% +$34.8K ﹤0.01% 1519
2022
Q3 		$1.13M Sell
57,457
-155
-0.3% -$3.3K ﹤0.01% 1555
2022
Q2 		$1.01M Buy
57,612
+14,435
+33% +$149K ﹤0.01% 1641
2022
Q1 		$425K Buy
+43,177
New +$570K ﹤0.01% 2293

Other funds holding DAWN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s DAWN Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) increased its Day One Biopharmaceuticals (DAWN) stake by 49% in Q1 2026, buying an estimated $168K and bringing the position to 36,186 shares worth $776K. The position accounts for ﹤0.01% of the portfolio, ranked #1959.

Manulife (Manufacturers Life Insurance) first reported a position in DAWN in Q1 2022 and has held it in 17 quarters since. The position peaked at $1.26M in Q4 2022. 207 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 36,186 shares of Day One Biopharmaceuticals worth $776K as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) bought 11,943 Day One Biopharmaceuticals shares in Q1 2026, an estimated $168K.
  • Day One Biopharmaceuticals made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #1959 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Day One Biopharmaceuticals in Q1 2022 and has held it in 17 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Day One Biopharmaceuticals position peaked at $1.26M in Q4 2022.
  • 207 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.